Arguably a slow start to September’s medtech financings, but I nonetheless expect it to pick up during the month, if not to the $400+ million month financings of July and August.
- Endosense, Inc., has raised $36 million in a Series B financing (catheter ablation of cardiac arrhythmias)
- Athena Feminine Technologies has raised $2 million in a Series A financing (pelvic floor electrical stimulation for treatment of urinary incontinence)
- ValenTx, Inc., has raised $22 million in Series B financing (minimally invasive treatment of obesity)
- LifeWave Hi-Tech Medical Devices Ltd has raised $1.5 million in a secondary offering (electrical stimulation device for chronic wound treatment)
Recent reports from MedMarket Diligence: